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Introduction 
Candida is a saprophytic yeast that is frequently recovered 
from the respiratory tract. Most Mycetoma lesions are due 
to Aspergillus species growing inside an existing cavity. 
Pulmonary disease caused by Cundida species is rare, even 
in patients who have leukaemia and who receive intensive 
chemotherapy. Only a few cases of mycetoma due to 
Cundida have been reported. We report a case of mycetoma 
caused by C. albicans in a tuberculous patient. Complete 
resolution occurred with antifungal therapy. 
Case report 
A 5%year-old male diabetic patient who was an ex-smoker 
was admitted in September 1995 with fever, cough, right 
pleuritic chest pain, frank haemoptysis, loss of appetite, 
general weakness and uncontrolled diabetes. 
He was already on continuation phase of antitubercular 
therapy as he was diagnosed a case of open pulmonary 
tuberculosis in October 1994. The organism was resistant to 
INH and PZA. 
The patient was thin and tall and clinically febrile 
(38.5”C) with right upper lobe consolidation. Laboratory 
examination showed normal white blood cells with leuko- 
cytosis, and blood glucose was 16.3 mmol- ‘. Culture of 
sputum for acid-fast bacilli (AFB) and non-specific organ- 
isms was negative. Blood culture was also negative. Tests 
for atypical organisms and viral study were negative. 
Antitubercular treatment was continued until sputum 
culture for AFB was reported negative. 
He was on insulin injection. He had a trial of antibiotics 
with no improvement. Bronchoscopy was performed which 
showed external compression of right upper lobe bronchus, 
otherwise normal. Bronchial specimens were negative for 
cancer cells, AFB and for pyogenic organisms but showed 
moderate growth of C. albicans. Sputum examination for 
fungus also showed profuse growth of C. albicans in 
consecutive samples. Two blood samples for Cundidu anti- 
gen were positive with titre value of 1:16. Precipitin anti- 
bodies against Candida, Aspergillus furnigatus, javus, niger 
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FIG. 1. CT scan of chest showing mycetoma in right 
upper lobe. 
and nidulans were not detected. A computed tomography 
(CT) scan of chest with contrast showed fibrotic lesions in 
both lungs, cystic area in right apex with a bulla. There was 
a cavity lesion with solid component in its dependent 
portion giving rise to crescent sign (Fig. 1). Right upper 
lobe bronchus was compressed by peribronchial thickening. 
He was put on injection Amphotericin-B for 3 weeks. After 
that he improved clinically as well as radiologically. He was 
then discharged from hospital on oral ketoconazole. A 
repeat blood test for Cundida antigen was negative in two 
consecutive samples after completing the course of anti- 
fungal treatment for a total of 60 days. 
Follow-up CT scan showed extensive fibrotic changes 
with cavities as in the previous CT but the fungus ball and 
its cavity almost completely resolved (Fig. 2). He remained 
well at 8 months follow-up. 
Discussion 
Pulmonary candidiasis is difficult to diagnose because the 
presence of Cundida in respiratory specimens may be due to 
contamination and there is no specific clinic0 radiological 
picture. Conclusive diagnosis requires demonstration of the 
organism in tissues (l-3). Lung involvement by Candida is 
either from haematogenous dissemination or aspiration 
from upper airways. The second possibility is more likely in 
our case as this mode of infection is particularly common in 
chronic debilitating disease (4). 
Pulmonary candidiasis can be present in four clinico- 
pathologic forms. (a), The disease can exist as a part of 
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FIG. 2. CT scan of chest after antifungal treatment show- 
ing almost complete resolution of mycetoma. 
systemic haematogenous infection associated with multi- 
organ involvement and a primary extrapulmonary site 
(usually gastrointestinal tract); (b), pulmonary candidiasis 
can occur as a primary infection that is presumably 
acquired by aspiration of organisms from the oral cavity. 
The infection may remain limited to the lung or may 
eventually disseminate; (c), the organism can accumulate in 
the airways in association with pulmonary disease and (d), 
it can occasionally manifest by a mycetoma. In our case 
Cundida presented as mycetoma in a pre-existing tubercu- 
lous cavity. Mycetoma due to Candida is a rare condition. 
Only few cases have been reported (S-9). This case was not 
confirmed by biopsy but certain points strongly favoured 
the diagnosis. The patient was mildly immunocompromised 
due to uncontrolled diabetes mellitus. Cundidu albicans was 
grown from bronchial and repeatedly from sputum samples 
and Cundidu antigen was positive from blood in high titre; 
sputum and bronchial specimen cultures were negative for 
pyogenic organisms as well as AFB. Blood culture for 
pyogenic organisms was negative. He failed to respond to 
ordinary antibiotics. CT scan showed a cavity with fungus 
ball in it. There was a good clinical as well as radiological 
response to antifungal therapy and Cundidu antigen became 
negative. Candida antigen detection was done using a 
latex agglutination kit (Cand-Tee, Ramco Laboratories, 
Houston, TX, U.S.A.) (10). The kit is based on a heat-labile 
cytoplasmic antigen and is specific in the presence of high 
titres (124 is significant). The test detects antigen for C. 
albicans and certain other species of Candida but not all of 
them. However repeated isolation of C. albicans in heavy 
growths and a very high titre (1:16) that decreased on 
therapy strengthens the contention that C. albicans was the 
aetiological agent. Further Aspergillus or any other fungus 
could neither be cultured nor detected by precipitin tests 
with patient’s serum. 
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